Cory Renauer
TMFang4apples
Cory Renauer is a contributing Healthcare Analyst at The Motley Fool, covering publicly traded companies across pharmaceuticals, biotechnology, and medical devices. Prior to The Motley Fool, Cory was an educator in Thailand and a laboratory technician for the American Red Cross. He holds a B.S. in Biology from Oakland University. Fun fact: Cory has a collection of novelty socks featuring famous stock market symbols and iconic investor quotes.
Recent Articles by Cory Renauer

May 24, 2025
by Cory Renauer
Does the 23andMe Acquisition Make Regeneron a Buy Now?

May 16, 2025
by Cory Renauer
Down 59%, Is UnitedHealth Group Stock a Buy on the Dip?

May 1, 2025
by Cory Renauer
Is Sofi Technologies Stock a Buy Now?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.